CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 3 filers reported holding CTI BIOPHARMA CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $253,928 | -66.5% | 60,459 | -62.8% | 0.00% | -83.3% |
| Q1 2022 | $758,000 | +715.1% | 162,309 | +331.4% | 0.01% | +500.0% |
| Q4 2021 | $93,000 | +27.4% | 37,626 | +52.4% | 0.00% | 0.0% |
| Q3 2021 | $73,000 | -39.7% | 24,688 | -40.6% | 0.00% | -50.0% |
| Q1 2021 | $121,000 | -78.0% | 41,593 | -75.6% | 0.00% | -75.0% |
| Q4 2020 | $549,000 | – | 170,583 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,684,404 | $21,876,000 | 9.07% |
| Lion Point Capital, LP | 5,489,546 | $25,636,000 | 5.95% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2,250,000 | $10,508,000 | 4.35% |
| Bleichroeder LP | 3,859,707 | $18,025,000 | 3.20% |
| NEA Management Company, LLC | 7,140,450 | $99,804,000 | 2.88% |
| BVF INC/IL | 8,929,690 | $41,702,000 | 1.67% |
| Ghost Tree Capital, LLC | 1,300,000 | $6,071,000 | 1.32% |
| EAM Investors, LLC | 1,011,935 | $4,726,000 | 0.88% |
| Knott David M Jr | 556,687 | $2,600,000 | 0.83% |
| Sofinnova Investments, Inc. | 1,952,691 | $9,119,000 | 0.69% |